GSTP1 and chronic myelogenous leukemia, BCR-ABL1 positive: The GSTP1 Ile105Val polymorphism has been widely investigated as a risk biomarker for various cancers, such as chronic myeloid leukemia [14], esophageal cancer [15], and bladder cancer [16], among others.